[Lecture] The Academic Report of Doctor Jonathan Frampton from University of Birmingham
Update Time:2022-06-16 10:05:00

Topic: The stem cell: A fundamental requirement for multicellular life and longevity with huge potential for the future of health and wellbeing

Beijing Time: June 16, 2022, Thursday, 16:30-18:00 

Venue: Aix-Marseille Smart Classroom S315, Chemical and Biological Building, Nanhu Campus

Zoom Cloud Meeting ID: 874 6624 8166

Password: 784375

Lecturer: Jonathan Frampton


Biography:

-PhD in Biological Sciences, University of Cambridge

-Vice-presidentofUniversity of Birmingham

-Professor of Stem Cell Biology and supervisor of PhD students in stem cell research at the Institute of Cancer and Genomic Sciences, School of Medicine and Dentistry, University of Birmingham

-Member of the UK Stem Cell Science Advisory Committee, UK Biological Sciences Research Council, and UK Medical Research Council Funding Committee

Dr. Frampton’s teaching expertise includes stem cell biology in molecular medicine, gene sequencing, gene function modelling, and genetic diseases. His main research interests lie in the mechanisms that determine the stem cells throughout life. He has over 30 years of experience in the transcriptional regulation of haematopoietic processes, with a focus on the mechanisms controlling stem cell maintenance and determining differentiation in haematological haemorrhagic disorders such as leukaemia. He is experienced in stem cells, haematological haemorrhagic cells, differentiation processes, developmental biology.the skills of using mouse genes to control gene expression, as well as cell analysis, particularly in cell flow techniques. He has held positions at the Beatson Institute for Cancer Research in Glasgow, the European Laboratory for Microbiology in Heidelberg, Germany, and the Weatherall Institute of Molecular Medicine, University of Oxford, respectively. Since 2011, he has been involved in more than 5 high level research collaborations with China.He has published over 100 high quality academic articles and publications in various 4* journals such as Cell, Immunity, Nature Medicine, Journal of Experimental Medicine, and EMBO Journal.


Rewritten by: Liu Kexi

Edited by: Li Tiantian

Source: School of Chemistry, Chemical Engineering and Bioscience, School of Aix-Marseille